about
Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational Cohort.Reliable assessment of the incidence of childhood autoimmune hemolytic anemia.Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study.A unique combination of inhibitory and partially activating mutations in β3 of a patient with variant-type Glanzmann thrombastheniaThe Rho3 and Rho4 small GTPases interact functionally with Wsc1p, a cell surface sensor of the protein kinase C cell-integrity pathway in Saccharomyces cerevisiaeTreatment with cyclosporin in auto-immune cytopenias in children: The experience from the French cohort OBS'CEREVANCESecond-line treatment trends and long-term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 years
P50
Q36101764-F6771C48-85EE-4A49-8DE3-98E7C91C3809Q38658384-5DF8FAC2-A689-4674-8162-18F751C4A3EDQ38819009-FC375FDF-BB44-459E-8902-44F8A0B60C0AQ57017106-47C6A491-9EE4-46D5-AF0E-BFF048DAE024Q82715699-444BD836-5ACC-492A-9E29-4B39DF6CA7C0Q88658047-B7DAD71D-5829-4779-867A-C8A4A6A20162Q90043673-68E7F6C4-1AAE-4BC5-9A42-9844AAFD2E3A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Helder Fernandes
@ast
Helder Fernandes
@en
Helder Fernandes
@es
Helder Fernandes
@nl
type
label
Helder Fernandes
@ast
Helder Fernandes
@en
Helder Fernandes
@es
Helder Fernandes
@nl
prefLabel
Helder Fernandes
@ast
Helder Fernandes
@en
Helder Fernandes
@es
Helder Fernandes
@nl
P106
P31
P496
0000-0001-8932-4383